GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

EKTA.B

49.72

-0.32%↓

AMBEA

132.4

-2.58%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

EKTA.B

49.72

-0.32%↓

AMBEA

132.4

-2.58%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

EKTA.B

49.72

-0.32%↓

AMBEA

132.4

-2.58%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

EKTA.B

49.72

-0.32%↓

AMBEA

132.4

-2.58%↓

GETI.B

212

+0.14%↑

CAMX

687.5

-5.76%↓

BIOAB

267.6

-1.18%↓

EKTA.B

49.72

-0.32%↓

AMBEA

132.4

-2.58%↓

Home・Akcijų sąrašas・Vitrolife AB

V
Vitrolife AB

Uždarymo kaina

134.5 -0.15

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

133.2

Max

136.6

Pagrindiniai rodikliai
By Trading Economics
Pajamos	31M 132M
Pardavimai	29M 871M
P/E Sektoriaus vid.	40.866 35.664
Pelnas, tenkantis vienai akcijai	0.74
Dividendų pajamingumas	0.8
Pelno marža	15.155
Darbuotojai	1,147
EBITDA	-119M 137M

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	0.80% 3.12%
Kitas uždarbis	2025-10-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.4B 19B
Ankstesnė atidarymo kaina	134.65
Ankstesnė uždarymo kaina	134.5

Vitrolife AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-15 22:39; UTC

Įsigijimai, susijungimai, perėmimai

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

2025-09-15 16:43; UTC

Pagrindinės rinkos jėgos

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

2025-09-15 16:42; UTC

Pagrindinės rinkos jėgos

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

2025-09-15 16:35; UTC

Pagrindinės rinkos jėgos

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

2025-09-15 23:46; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-15 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

2025-09-15 23:34; UTC

Rinkos pokalbiai

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

2025-09-15 22:48; UTC

Rinkos pokalbiai

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

2025-09-15 22:12; UTC

Įsigijimai, susijungimai, perėmimai

CSL Expects Commercial Launch in 2029

2025-09-15 22:12; UTC

Įsigijimai, susijungimai, perėmimai

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

2025-09-15 22:11; UTC

Įsigijimai, susijungimai, perėmimai

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

2025-09-15 22:11; UTC

Įsigijimai, susijungimai, perėmimai

CSL to Have Right to Exercise Option Based on Phase 3 Data

2025-09-15 22:10; UTC

Įsigijimai, susijungimai, perėmimai

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

2025-09-15 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

2025-09-15 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

2025-09-15 21:15; UTC

Įsigijimai, susijungimai, perėmimai

Chord Energy to Buy 48,000 Net Acres in the Williston Core

2025-09-15 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

2025-09-15 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-09-15 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-09-15 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-15 19:29; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

2025-09-15 19:14; UTC

Rinkos pokalbiai

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

2025-09-15 18:16; UTC

Rinkos pokalbiai

Gold Powers to New High -- Market Talk

2025-09-15 18:05; UTC

Rinkos pokalbiai

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

2025-09-15 17:50; UTC

Įsigijimai, susijungimai, perėmimai

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

2025-09-15 17:10; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-09-15 17:10; UTC

Rinkos pokalbiai

S&P Expects Fed, BOC to Cut Rates -- Market Talk

2025-09-15 16:52; UTC

Rinkos pokalbiai

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

2025-09-15 16:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-09-15 16:20; UTC

Rinkos pokalbiai

Uždarbis

Auto & Transport Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Vitrolife AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.